share_log

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

AneBulo製藥第一季度每股收益為0.11美元,較上年同期下降0.07美元
Benzinga Real-time News ·  2022/11/10 08:07

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share. This is a 57.14 percent decrease over losses of $(0.07) per share from the same period last year.

納斯達克(AneBulo PharmPharmticals)公佈季度每股虧損0.11美元。這比去年同期每股虧損0.07美元減少了57.14%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論